Beam Therapeutics
BEAM
BEAM
212 hedge funds and large institutions have $2.59B invested in Beam Therapeutics in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 54 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
8% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 36
1% less funds holding
Funds holding: 215 → 212 (-3)
2.43% less ownership
Funds ownership: 107.78% → 105.35% (-2.4%)
Holders
212
Holding in Top 10
4
Calls
$23.9M
Puts
$15M
Top Buyers
| 1 | +$53.2M | |
| 2 | +$37.2M | |
| 3 | +$28.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.99M |
| 5 |
IEFM
IQ EQ Fund Management
Dublin 2,
Ireland
|
+$4.57M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$30.8M | |
| 3 | -$16.1M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$12.7M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.2M |
